USFDA Audit Cleared - Bioanalytical Facility successfully closed an unannounced audit with zero observations | Global Recognition - CDMO Division participated as a Sponsor and Emerging Tech Partner at the European Pharma Outsourcing Summit (EPOS), Germany | Expanding Manufacturing Capabilities with enhanced capacity Dry Granulation (Roll Compactor), Low RH Manufacturing & High-Speed Capsule Filling

Research & Development

Pharma Products - Research and Development

Our Formulation R&D team brings extensive expertise across Oral Solids (small molecules and peptide-based APIs), Oral Liquids, Powders / Granules / PFOS, FTF/non-infringing strategies and complex/hybrid formulations, enabling innovative solutions tailored to diverse development needs.

Product Development

We have expertise in various technologies for development of conventional to complex delivery systems. We are well versed with the application of Quality by Design concept throughout the development process for delivery of robust products.

We have capability to develop high potent molecules (up to OEB 3) in our special product area which is designed to handle such molecules.

We have successfully developed more than 50 products, including NCE -1, complex generics and innovative combination products.

Our product development team includes qualified scientists with diverse experience in different technologies and scientific expertise.

Our Expertise

  • OSD (ORAL SOLID DOSAGE FORMS) – Potent (OEB 3) / Non-potent, Small Molecules, Peptide-based Actives
    • Tablets:
      • Bi-layered Tablets
      • MUPS (multi-unit particulate system)
      • ODTs (Orally Disintegrating Tablets)
      • Sublingual Tablets
      • Effervescent Tablets
    • HG Capsules:
      • Powder
      • Granules
      • Pellets filled in capsules
    • FDCs (Fixed Dose Combinations)
    • SR / DR / MR Dosage Forms
  • ORAL LIQUIDS:
    • Solutions
    • Suspensions
    • Emulsions
  • POWDERS / GRANULES / PFOS (POWDER FOR ORAL SUSPENSION) – Bottles & Sachet Packs
  • PATENT NON-INFRINGEMENT STRATEGIES
  • COMPLEX / HYBRID FORMULATIONS

Development Specialites

Quality

State of the art infrastructure

Customer focus

Analytical Development

State of the art Analytical R&D facility to meet the ever-rising demands of the global healthcare industry. Experience scientists and advanced capabilities lead to fast and scientifically sound results. We help streamline drug products development and are focused on accelerating the product development cycle in a quality compliant manner.

Analytical Development Services:

Equipment Capabilities:

Achievements:

Development Quality Assurance

VerGo Pharma’s R&D is integrated with inhouse Development Quality Assurance team which ensures compliance to all quality procedure during routine Research & Development activities.

Major Responsibilities:

Partner with VerGo Pharma for Innovative & Commercially viable R&D Solutions